Story
9 Oct 2008
Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions
See all tags
See all tags
Abbott Laboratories
Aspen Pharmacare
AMB Generali
Aurobindo Pharmaceuticals
bioMérieux
BD (Becton, Dickinson)
Boehringer Ingelheim
GlaxoSmithKline
Gilead Sciences
Hetero
Inverness Medical Innovations
Johnson & Johnson
Merck
Matrix Laboratories (part of Mylan Laboratories)
Pfizer
Roche
Ranbaxy Laboratories
Shanghai Kehua Bio-Engineering
Restricted access to medicines
Intellectual Property
UN Sustainable Development Goals (SDGs) / Millennium Development Goals
WHO
UNICEF
UNAIDS
UNDP
UN Secretary-General
World Trade Organisation (WTO)
People living with HIV/AIDs
Company Support for Initiatives Promoting Development, Economic and Social Rights
UN